Inavya Ventures Ltd.

Inavya was Co-Founded by Dr Michael Wilkinson and Aleardo Furlani in 2015, and is based in London. Inavya has created AVATR - a novel CE Marked medical device and artificial intelligence platform that enables a person to create, own and share their digital profile to receive remote and highly personalised medical care. Inavya has clinical initiatives running globally. The team has been developing novel GenAI and Agentic AI technology to support remote healthcare and bio-technology R&D, with support from Microsoft. UK: The UK government selected Inavya as a One World Company, and a First 100 Playbook Company. Globally: In 2024 Inavya was awarded Top-10 Innovator (Innovation in Business, UK), Top-10 Startup to Watch (CEO Magazine, USA), and Top-5 HealthTech Company to Watch (Silicon Review, USA). Thus far in 2025, Inavya has been awarded Top-10 Innovation Company to Watch (CEO Magazine, USA). Inavya Board of Directors: Michael Wilkinson (Co-Founder; CEO), Aleardo Furlani (Co-Founder; NED), Jack Tsang (NED), Della Burnside (NED) Contact Info: info@inavya.com